Background:

In 2017, the National Cancer Registration Center showed that about 10 thousand people were diagnosed with cancer every day, with an average of 7 people per minute, and the burden of cancer in China was serious.

In 2016, Chinese cardiovascular and cerebrovascular disease reports showed that the number of cardiovascular patients in China was about 290 million, and about 3 million 500 thousand people died of cardiovascular disease every year, accounting for 41% of the causes of death.

Product introduction:

Yinfeng susceptibility gene detection is based on the China population genetic characteristics of the disease risk assessment products. Genetic testing can effectively assess the genetic risk of various diseases, and provide personalized guidance plan according to the level of risk, so as to achieve early prediction, early prevention and early treatment.

Detection significance:

1. the rapid diagnosis of disease and the discovery of the cause of disease

2. prediction of disease development and prevention of complications

3. guidance on individualized treatment

4. develop personalized health programs for patients

Intended for：